Dr Foster's case notes

September 2004
BMJ: British Medical Journal (International Edition);9/18/2004, Vol. 329 Issue 7467, p645
Academic Journal
Examines the relationship between the prescribing of lipid regulating drugs or statins to the number of admissions for myocardial infarction in England. Conduct of the study; Finding that the large increase in the cost and volume of the prescribing of lipid regulating drugs has been associated with only a modest reduction in admission rates for heart attacks; Belief that further study is needed which takes into account other risk factors such as smoking, hypertension and diabetes in patients who suffer cardiac arrest.


Related Articles

  • A Comparison of Echocardiography, Nuclear Stress Testing, and CT Scanning. Garcia, Mario J.; Berman, Daniel; Travin, Mark // Medical Roundtable: Cardiovascular Edition;Spring2012, Vol. 3 Issue 2, p95 

    The article presents an Expert Roundtable Discussion on the diagnostic tests available for patients with coronary artery disease including echocardiography, nuclear stress testing, and computed tomographic (CT) scanning. Doctor Daniel Berman says that the group of patients are those who are...

  • Review: diabetes is not a coronary disease equivalent.  // Evidence Based Medicine;Oct2009, Vol. 14 Issue 5, p5 

    The article presents a review regarding the possibility of patients with diabetes without history of myocardial infarction (MI) to have similar risk to patients with coronary artery disease (CAD) and with previous MI and no diabetes. Researchers conducted a cohort study involving 100 patients...

  • THE INFLUENCE OF DIABETES MELLITUS ON MORBIDITY AND MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN JABLANICA DISTRICT. Pavlović, Jovana; Đinđić, Boris; Pavlović, Andrej; Pavlović, Jovica; Kostić, Marija // Acta Medica Medianae;Sep2013, Vol. 52 Issue 3, p5 

    This study examines the influence of diabetes mellitus type 2 (DM type 2) on morbidity and mortality in patients after acute myocardial infarction (AMI). The study included 261 patients with acute myocardial infarction, treated at the General Hospital in Leskovac during the period from January...

  • Statins bring long-term falls in non-CVD disease. Anekwe, Lilian // Pulse;9/7/2011, Vol. 71 Issue 28, p15 

    The article reports on the result of a study conducted by researchers in Great Britain, which shows that long-term intake of statins decreases the risk of non-fatal myocardial infarction and fatal coronary heart disease (CHD).

  • Why you have to treat an M.I. false alarm as a high risk. Lee, Anthony A. // RN;Jul77, Vol. 40 Issue 7, p52 

    Suggests the needs for patients to consider patients suspected of having myocardial infarction (MI) as high risk patients. Details on the findings of study conducted at Stanford University Medical Center about high risk MI patients; Emergency department care for suspected MI patients; Discharge...

  • Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study. Chapman, Richard H.; Petrilla, Allison A.; Berman, Lance; Benner, Joshua S.; Tang, Simon S. K. // American Journal of Cardiovascular Drugs;2009, Vol. 9 Issue 5, p299 

    Background: Treatment guidelines for dyslipidemic patients have focused on lipid levels and risk assessments. However, normolipidemic patients who have multiple risk factors for cardiovascular disease may also benefit from HMG-CoA reductase inhibitor (statin) therapy. Objective: We examined the...

  • Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease. Nissen, Steven E.; Tuzcu, E. Murat; Schoenhagen, Paul; Crowe, Tim; Sasiela, William J.; Tsai, John; Orazem, John; Magorien, Raymond D.; O'Shaughnessy, Charles; Ganz, Peter // New England Journal of Medicine;1/6/2005, Vol. 352 Issue 1, p29 

    Background: Recent trials have demonstrated better outcomes with intensive than with moderate statin treatment. Intensive treatment produced greater reductions in both low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP), suggesting a relationship between these two biomarkers...

  • Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation. Nhat-Tu Le; Corsetti, James P.; Dehoff-Sparks, Janet L.; Sparks, Charles E.; Keigi Fujiwara; Jun-ich Abe // International Journal of Inflammation;2012, p1 

    Although the exact mechanism through which NADPH oxidases (Nox's) generate reactive oxygen species (ROS) is still not completely understood, it is widely considered that ROS accumulation is the cause of oxidative stress in endothelial cells. Increasing pieces of evidence strongly indicate the...

  • New benefits in statin interaction with newer antihypertensives.  // Pulse;11/19/2005, Vol. 65 Issue 45, p13 

    The article reports on the result of the sub-study conducted by Ascot in statin interaction with antihypertensive drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics